FEB 19, 2020 9:32 PM PST

Antibiotics Linked to Birth Defects in Pregnant Women

WRITTEN BY: Nouran Amin

Pregnant women prescribed macrolide antibiotics during the first trimester of pregnancy place their children at an increased risk of major birth defects in comparison with penicillin. A recent study calls for the cautionary use of these drugs.

"Macrolide antibiotics are used to treat a wide variety of bacterial infections, and are among the most frequently prescribed antibiotics during pregnancy in Western countries,” said lead author and PhD candidate, Heng Fan of UCL Great Ormond Street Institute of Child Health.

The study was focused on assessing the association between macrolides and major malformations at birth such as heart, genital defects, and neurodevelopmental disorders (cerebral palsy, epilepsy, ADHD, and autism spectrum disorder).

"This work builds on previous evidence of rare but serious adverse outcomes of macrolide use, especially for unborn babies. These adverse outcomes were assumed to be associated with the arrhythmic effect of macrolides and policy advice about their use in pregnancy varies,” added Feng. “If the associations are shown to be causal, these findings suggest that an additional four children would be born with cardiovascular malformations for every 1,000 children exposed to macrolides instead of penicillins in the first trimester of pregnancy."

To come to major findings, researchers analyzed data from 104,605 children born in the UK from 1990 to 2016 using the Clinical Practice Research Datalink (CPRD) mothers were prescribed macrolides or penicillins before pregnancy, and 53,735 children who were siblings of children in the study group acted as control (comparison) cohorts.

"Our findings suggest it would be better to avoid macrolides during pregnancy if alternative antibiotics can be used,” notes Professor Ruth Gilbert (UCL Great Ormond Street Institute of Child Health). "Women should not stop taking antibiotics when needed, as untreated infections are a greater risk to the unborn baby."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 13, 2020
Drug Discovery & Development
FDA Fast Tracks Vaccine for COVID-19
MAY 13, 2020
FDA Fast Tracks Vaccine for COVID-19
Biopharmaceutical company, Moderna, has announced that the US Food and Drug Administration has approved its experimental ...
MAY 21, 2020
Cancer
A New Player in the Regulation of Cancer's Microenvironment
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
MAY 23, 2020
Cancer
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
MAY 23, 2020
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
Breast cancer, one of the most common cancers in the world, are commonly separated into one of several sub-types. These ...
JUN 03, 2020
Drug Discovery & Development
A Drug That Deletes Cravings?
JUN 03, 2020
A Drug That Deletes Cravings?
No More Cravings? Scientists at Duke University may have created a drug to hone cravings and possibly help with weight m ...
JUN 24, 2020
Drug Discovery & Development
Gilead to Test Inhalable Remdesivir Against COVID-19
JUN 24, 2020
Gilead to Test Inhalable Remdesivir Against COVID-19
Gilead has announced that it will soon start trials for an inhalable form of Remdesivir, the first drug to receive Emerg ...
JUL 08, 2020
Drug Discovery & Development
Common Blood Pressure Drugs May Prevent Colon Cancer
JUL 08, 2020
Common Blood Pressure Drugs May Prevent Colon Cancer
Colon cancer is the third most common cancer and the second leading cause of death by cancer around the world. Now, rese ...
Loading Comments...